Mitiglinide Calcium Hydrate is mainly used to manage type 2 diabetes by helping regulate blood sugar levels. It works by stimulating the release of insulin from the pancreas after meals, effectively lowering blood sugar. It is often used in combination with other antidiabetic medications to achieve better glycemic control. It is grouped under the following drug class(es): Hypoglycemics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Glufast, Mitiglinide calcium dihydrate and Mitiglinide calcium salt dihydrate. Its PubChem CID is 6918235.
Mitiglinide calcium hydrate
| CAS No | 207844-01-7 |
|---|---|
| Molecular Formula | C38H52CaN2O8 |
| Molecular Weight | 704.90 g/mol |
| Synonyms | calcium;bis((2S)-4-[(3aR,7aS)-1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl]-2-benzyl-4-oxobutanoate);dihydrate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Mitiglinide Calcium Hydrate is mainly used to manage type 2 diabetes by helping regulate blood sugar levels. It works by stimulating the release of insulin from the pancreas after meals, effectively lowering blood sugar.
The listed CAS number is 207844-01-7.
The listed molecular formula is C38H52CaN2O8.
The listed molecular weight is 704.90 g/mol.
calcium;bis((2S)-4-[(3aR,7aS)-1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl]-2-benzyl-4-oxobutanoate);dihydrate.
The source lists Glufast, Mitiglinide calcium dihydrate and Mitiglinide calcium salt dihydrate.